Coloplast A/S
F:CBH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coloplast A/S
F:CBH
|
DK |
|
S
|
Swatch Group AG
XMUN:UHRN
|
CH |
|
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
JP |
|
F
|
Federal Home Loan Mortgage Corp
DUS:FHL
|
US |
|
Old Second Bancorp Inc
F:OSB
|
US |
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
C
|
Cloudflare Inc
DUS:8CF
|
US |
|
F
|
Federal Home Loan Mortgage Corp
F:FHL
|
US |
|
E
|
Elvalhalcor Hellenic Copper and Aluminium Industry SA
ATHEX:ELHA
|
GR |
Wall St Price Targets
CBH Price Targets Summary
Coloplast A/S
According to Wall Street analysts, the average 1-year price target for CBH is 7.27 EUR with a low forecast of 5.28 EUR and a high forecast of 9.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CBH's stock price target?
Price Target
7.27
EUR
According to Wall Street analysts, the average 1-year price target for CBH is 7.27 EUR with a low forecast of 5.28 EUR and a high forecast of 9.61 EUR.
What is the Revenue forecast for Coloplast A/S?
Projected CAGR
7%
Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Coloplast A/S?
Projected CAGR
7%
Over the last 9 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Coloplast A/S?
Projected CAGR
16%
Over the last 9 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 5 years is 16%.
